Your browser doesn't support javascript.
loading
Fabrication on the microscale: a two-photon polymerized device for oocyte microinjection.
Yagoub, Suliman H; Thompson, Jeremy G; Orth, Antony; Dholakia, Kishan; Gibson, Brant C; Dunning, Kylie R.
Affiliation
  • Yagoub SH; Australian Research Council (ARC) Centre of Excellence for Nanoscale BioPhotonics (CNBP), Adelaide, South Australia, 5000, Australia.
  • Thompson JG; University of Adelaide, Robinson Research Institute, School of Biomedicine, Adelaide, South Australia, 5005, Australia.
  • Orth A; Institute for Photonics and Advanced Sensing (IPAS), University of Adelaide, Adelaide, South Australia, 5000, Australia.
  • Dholakia K; Australian Research Council (ARC) Centre of Excellence for Nanoscale BioPhotonics (CNBP), Adelaide, South Australia, 5000, Australia.
  • Gibson BC; University of Adelaide, Robinson Research Institute, School of Biomedicine, Adelaide, South Australia, 5005, Australia.
  • Dunning KR; Institute for Photonics and Advanced Sensing (IPAS), University of Adelaide, Adelaide, South Australia, 5000, Australia.
J Assist Reprod Genet ; 39(7): 1503-1513, 2022 Jul.
Article de En | MEDLINE | ID: mdl-35552947
ABSTRACT

PURPOSE:

Intracytoplasmic sperm injection (ICSI) addresses male sub-fertility by injecting a spermatozoon into the oocyte. This challenging procedure requires the use of dual micromanipulators, with success influenced by inter-operator expertise. We hypothesized that minimizing oocyte handling during ICSI will simplify the procedure. To address this, we designed and fabricated a micrometer scale device that houses the oocyte and requires only one micromanipulator for microinjection.

METHODS:

The device consisted of 2 components, each of sub-cubic millimeter volume a Pod and a Garage. These were fabricated using 2-photon polymerization. Toxicity was evaluated by culturing single-mouse presumptive zygotes (PZs) to the blastocyst stage within a Pod, with several Pods (and embryos) docked in a Garage. The development was compared to standard culture. The level of DNA damage/repair in resultant blastocysts was quantified (γH2A.X immunohistochemistry). To demonstrate the capability to carry out ICSI within the device, PZs were microinjected with 4-µm fluorescent microspheres and cultured to the blastocyst stage. Finally, the device was assessed for oocyte traceability and high-throughput microinjection capabilities and compared to standard microinjection practice using key parameters (pipette setup, holding then injecting oocytes).

RESULTS:

Compared to standard culture, embryo culture within Pods and a Garage showed no differences in development to the blastocyst stage or levels of DNA damage in resultant blastocysts. Furthermore, microinjection within our device removes the need for a holding pipette, improves traceability, and facilitates high-throughput microinjection.

CONCLUSION:

This novel device could improve embryo production following ICSI by simplifying the procedure and thus decreasing inter-operator variability.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ovocytes / Sperme Limites: Animals Langue: En Journal: J Assist Reprod Genet Sujet du journal: GENETICA / MEDICINA REPRODUTIVA Année: 2022 Type de document: Article Pays d'affiliation: Australie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ovocytes / Sperme Limites: Animals Langue: En Journal: J Assist Reprod Genet Sujet du journal: GENETICA / MEDICINA REPRODUTIVA Année: 2022 Type de document: Article Pays d'affiliation: Australie